Mefloquine and Attention deficit hyperactivity disorder - a phase IV clinical study of FDA data
Attention deficit hyperactivity disorder is reported only by a few people who take Mefloquine.
The phase IV clinical study analyzes which people take Mefloquine and have Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 836 people who have side effects while taking Mefloquine from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
836 people reported to have side effects when taking Mefloquine.
Among them, 4 people (0.48%) have Attention deficit hyperactivity disorder.
What is Mefloquine?
Mefloquine has active ingredients of mefloquine hydrochloride. It is often used in malaria. eHealthMe is studying from 924 Mefloquine users for its effectiveness, alternative drugs and more.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 1,475 drugs and 1,196 conditions by eHealthMe.
Number of Mefloquine and Attention deficit hyperactivity disorder reports submitted per year:
Time on Mefloquine when people have Attention deficit hyperactivity disorder *:
- < 1 month: 33.33 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 33.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Attention deficit hyperactivity disorder when taking Mefloquine *:
- female: 25 %
- male: 75 %
Age of people who have Attention deficit hyperactivity disorder when taking Mefloquine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 25 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 75 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Mefloquine *:
- Vyvanse: 1 person, 25.00%
- Ibuprofen: 1 person, 25.00%
- Adenosine: 1 person, 25.00%
- Alprazolam: 1 person, 25.00%
- Ammonium Lactate: 1 person, 25.00%
- Anusol Hc: 1 person, 25.00%
- Atropine: 1 person, 25.00%
- Benzonatate: 1 person, 25.00%
- Bisoprolol Fumarate: 1 person, 25.00%
- Diazepam: 1 person, 25.00%
Common side effects people have besides Attention deficit hyperactivity disorder *:
- Stress And Anxiety: 2 people, 50.00%
- Fatigue (feeling of tiredness): 2 people, 50.00%
- Weight Decreased: 1 person, 25.00%
- Dry Mouth: 1 person, 25.00%
- High Blood Cholesterol: 1 person, 25.00%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 25.00%
- Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 25.00%
- Glycosuria (excretion of glucose into the urine): 1 person, 25.00%
- Gait Abnormal: 1 person, 25.00%
- Fall: 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Mefloquine and have Attention deficit hyperactivity disorder?Check whether Attention deficit hyperactivity disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How severe was Attention deficit hyperactivity disorder and when was it recovered:
Expand to all the drugs that have ingredients of mefloquine hydrochloride:
- Attention deficit hyperactivity disorder and drugs with ingredients of mefloquine hydrochloride (26 reports)
Alternative drugs to, pros and cons of Mefloquine:
- Mefloquine (924 reports)
Common Mefloquine side effects:
Browse all side effects of Mefloquine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Attention deficit hyperactivity disorder treatments and more:
- Attention deficit hyperactivity disorder (106,176 reports)
COVID vaccines that are related to Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder in Moderna COVID Vaccine
- Attention deficit hyperactivity disorder in Pfizer BioNTech Covid Vaccine
- Attention deficit hyperactivity disorder in Johnson and Johnson Covid Vaccine
Common drugs associated with Attention deficit hyperactivity disorder:
All the drugs that are associated with Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder (1,475 drugs)
Common conditions associated with Attention deficit hyperactivity disorder:
All the conditions that are associated with Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder (1,196 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mefloquine hydrochloride (the active ingredients of Mefloquine) and Mefloquine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Allegra and Osteonecrosis Of Jaw - 6 seconds ago
- Toradol and Iron Deficiency Anaemia - 7 seconds ago
- Fluconazole and Duodenal Ulcer Aggravated - 8 seconds ago
- Carbidopa And Levodopa and Compulsive Shopping - 14 seconds ago
- Zoloft and Teveten drug interaction - 15 seconds ago
- Trimox and Aspirin drug interaction - 15 seconds ago
- Atropine Sulfate and Nausea And Vomiting - 17 seconds ago
- Bevespi Aerosphere and Basaglar drug interaction - 18 seconds ago
- Divigel and Fainting - 18 seconds ago
- Benadryl and Mebendazole drug interaction - 24 seconds ago